We are live on ! Find out more
GLSI icon

Greenwich LifeSciences
GLSI

21 hedge funds and large institutions have $7.21M invested in Greenwich LifeSciences in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.76% less ownership

Funds ownership: 7.94% → 6.18% (-1.8%)

17% less capital invested

Capital invested by funds: $8.74M → $7.21M (-$1.53M)

38% less funds holding

Funds holding: 34 → 21 (-13)

56% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 9

87% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 15

Holders
21
Holders Change
-13
Holders Change %
-38.24%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
9
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PVI
Pura Vida Investments
New York
+$182K
2
Ameriprise
Ameriprise
Minnesota
+$181K
3
HF
HRT Financial
New York
+$111K
4
Bank of America
Bank of America
North Carolina
+$50.1K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$11.8K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$448K
2
Morgan Stanley
Morgan Stanley
New York
-$351K
3
Millennium Management
Millennium Management
New York
-$282K
4
OQS
Occudo Quantitative Strategies
Florida
-$199K
5
Two Sigma Investments
Two Sigma Investments
New York
-$182K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.13M -$90.7K -9,800 -3%
Marshall Wace
2
Marshall Wace
United Kingdom
$702K -$119K -12,813 -14%
Ameriprise
3
Ameriprise
Minnesota
$561K +$181K +19,520 +46%
Millennium Management
4
Millennium Management
New York
$544K -$282K -30,479 -34%
Renaissance Technologies
5
Renaissance Technologies
New York
$516K -$448K -48,458 -46%
BlackRock
6
BlackRock
New York
$462K -$2.22K -240 -0.5%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$384K +$11.8K +1,280 +3%
Morgan Stanley
8
Morgan Stanley
New York
$321K -$351K -37,955 -52%
PVI
9
Pura Vida Investments
New York
$179K +$182K +19,667 New
Bank of America
10
Bank of America
North Carolina
$146K +$50.1K +5,416 +51%
State Street
11
State Street
Massachusetts
$118K – – –
HF
12
HRT Financial
New York
$109K +$111K +12,029 New
UBS Group
13
UBS Group
Switzerland
$17K +$8.69K +939 +108%
FCMT
14
Founders Capital Management (Texas)
Texas
$9K – – –
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$6K -$6.47K -699 -50%
NFSG
16
Newbridge Financial Services Group
Florida
$5K – – –
Fidelity Investments
17
Fidelity Investments
Massachusetts
$1K -$444 -48 -34%
OQS
18
Occudo Quantitative Strategies
Florida
– -$199K -23,440 Closed
Two Sigma Investments
19
Two Sigma Investments
New York
– -$182K -21,431 Closed
E
20
Ergoteles
New York
– -$169K -20,000 Closed
SSA
21
Schonfeld Strategic Advisors
New York
– -$151K -17,800 Closed
Citadel Advisors
22
Citadel Advisors
Florida
– -$150K -17,657 Closed
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
– -$149K -17,631 Closed
CSS
24
Cubist Systematic Strategies
Connecticut
– -$130K -15,332 Closed
Goldman Sachs
25
Goldman Sachs
New York
– -$104K -12,322 Closed
1
2

GLSI Hedge Fund Activity: Q3 2022 in Review

21 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q3 2022, worth a combined $7.21M — down 17% from $8.74M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of GLSI and 2 opened new positions — a net loss of 13 holders — while 9 trimmed existing stakes and 4 added.

The largest buyer was Pura Vida Investments, opening a new position worth an estimated $182K. The largest seller was Renaissance Technologies, cutting an estimated $448K.

  • 21 institutional investors held Greenwich LifeSciences (GLSI) as of Q3 2022, down from 34 in Q2 2022.
  • Funds reported $7.21M of Greenwich LifeSciences stock for Q3 2022, down 17% quarter-over-quarter.
  • 2 funds opened new Greenwich LifeSciences positions in Q3 2022 and 15 closed out, a net change of -13 holders.
  • The largest Greenwich LifeSciences buyer in Q3 2022 was Pura Vida Investments, an estimated $182K added.
  • The largest Greenwich LifeSciences seller in Q3 2022 was Renaissance Technologies, an estimated $448K sold.

Based on aggregated 13F filings for Q3 2022.